Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2452-2021Class II

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Cellex / initiated 2021-03-01 / Open, Classified

Cellex began a recall of Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue" on . FDA classified it as Class II and gives the reason as "The kit does not have an emergency use authorization (EUA)". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2452-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Cellex
Product
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
Product code
QKP Coronavirus Antigen Detection Test System.
Reason for recall
The kit does not have an emergency use authorization (EUA).
FDA root cause
Under Investigation by firm
Action
The recall was initiated via phone. The date the telephone calls were made is unknown but may have occurred late February, early March, 2021, based on the date returns started being made to the recalling firm. The firm issued their initial letters dated 6/15/2021 via email as a result of not having documentation of the phone calls. Later notifications were also issued or verbally discussed, with the latest notification occurring 8/20/2021.
Quantity in commerce
Approximately 44,821 kits
Distribution
US Nationwide distribution in the states of CA, FL, TX, and WI.
Product codes and lots
All lot numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2452-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2452-2021Class IIOngoingVoluntary: Firm initiated